Hims & Hers Health (HIMS) Amortization of Deferred Charges (2020 - 2026)

Hims & Hers Health's (HIMS) quarterly Amortization of Deferred Charges came in at $1.7 million in Q1 2026, down 2.19% quarter-over-quarter from $1.7 million in Q4 2025.

Hims & Hers Health (HIMS) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Hims & Hers Health has disclosed Amortization of Deferred Charges across 4 years of filings, most recently posting $1.7 million for Q1 2026.

  • Amortization of Deferred Charges for Q1 2026 came in at $1.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 million (changed N/A YoY), and the FY2025 annual result was $4.5 million, changed N/A from the prior year.
  • Amortization of Deferred Charges came in at $1.7 million for Q1 2026 at Hims & Hers Health, down from $1.7 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $1.7 million in Q4 2025 to a low of $1.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.70 Mn
Mar 31, 2026 1.70 Mn
Dec 31, 2025 1.74 Mn
Dec 31, 2025 1.74 Mn
Sep 30, 2025 1.60 Mn
Sep 30, 2025 1.60 Mn
Mar 31, 2021 144,000.00
Mar 31, 2021 144,000.00
Dec 31, 2020 71,000.00
Dec 31, 2020 71,000.00
Sep 30, 2020 84,000.00
Sep 30, 2020 84,000.00
Jun 30, 2020 83,000.00
Jun 30, 2020 83,000.00
Mar 31, 2020 84,000.00
Mar 31, 2020 84,000.00